Natera Return on Tangible Equity 2014-2024 | NTRA
Natera Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2024-09-30 | $-0.22B | $0.88B | -26.26% |
2024-06-30 | $-0.29B | $0.84B | -36.72% |
2024-03-31 | $-0.37B | $0.79B | -49.80% |
2023-12-31 | $-0.44B | $0.77B | -62.21% |
2023-09-30 | $-0.50B | $0.79B | -73.05% |
2023-06-30 | $-0.51B | $0.60B | -88.47% |
2023-03-31 | $-0.55B | $0.65B | -100.92% |
2022-12-31 | $-0.55B | $0.71B | -106.67% |
2022-09-30 | $-0.55B | $0.36B | -109.09% |
2022-06-30 | $-0.58B | $0.45B | -96.04% |
2022-03-31 | $-0.55B | $0.54B | -97.11% |
2021-12-31 | $-0.47B | $0.65B | -90.64% |
2021-09-30 | $-0.41B | $0.76B | -84.97% |
2021-06-30 | $-0.31B | $0.30B | -74.19% |
2021-03-31 | $-0.26B | $0.37B | -60.78% |
2020-12-31 | $-0.23B | $0.49B | -57.79% |
2020-09-30 | $-0.19B | $0.54B | -54.57% |
2020-06-30 | $-0.15B | $0.30B | -66.02% |
2020-03-31 | $-0.13B | $0.26B | -69.83% |
2019-12-31 | $-0.12B | $0.28B | -107.36% |
2019-09-30 | $-0.12B | $0.09B | -225.12% |
2019-06-30 | $-0.13B | $0.09B | -273.80% |
2019-03-31 | $-0.13B | $0.01B | -722.22% |
2018-12-31 | $-0.13B | $0.03B | -819.05% |
2018-09-30 | $-0.14B | $0.06B | -1028.57% |
2018-06-30 | $-0.14B | $-0.02B | -1958.62% |
2018-03-31 | $-0.14B | $-0.00B | -537.25% |
2017-12-31 | $-0.14B | $0.03B | -304.44% |
2017-09-30 | $-0.13B | $0.03B | -202.30% |
2017-06-30 | $-0.13B | $0.05B | -140.16% |
2017-03-31 | $-0.12B | $0.07B | -102.48% |
2016-12-31 | $-0.10B | $0.11B | -67.57% |
2016-09-30 | $-0.08B | $0.14B | -48.29% |
2016-06-30 | $-0.07B | $0.16B | -39.62% |
2016-03-31 | $-0.07B | $0.18B | -45.45% |
2015-12-31 | $-0.07B | $0.19B | -65.44% |
2015-06-30 | $-0.03B | $0.04B | -279.07% |
2015-03-31 | $-0.01B | inf% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $20.871B | $1.083B |
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $84.995B | 10.55 |
Cencora (COR) | United States | $43.734B | 16.44 |
DiDi Global (DIDIY) | China | $22.941B | 0.00 |
ICON (ICLR) | Ireland | $16.879B | 15.03 |
Viatris (VTRS) | United States | $14.478B | 4.46 |
Avantor (AVTR) | United States | $14.307B | 21.45 |
Revvity (RVTY) | United States | $13.453B | 23.37 |
BioMerieux (BMXMF) | France | $12.659B | 0.00 |
CochLear (CHEOY) | Australia | $11.807B | 0.00 |
Solventum (SOLV) | United States | $11.540B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
Doximity (DOCS) | United States | $10.302B | 60.64 |
Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
HealthEquity (HQY) | United States | $8.212B | 41.20 |
Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
Sotera Health (SHC) | United States | $3.759B | 20.11 |
Organon (OGN) | United States | $3.719B | 3.75 |
BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
Concentras Parent (CON) | United States | $2.491B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
Premier (PINC) | United States | $2.067B | 10.76 |
PACS (PACS) | United States | $1.992B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
Progyny (PGNY) | United States | $1.208B | 24.47 |
Embecta (EMBC) | United States | $1.161B | 8.12 |
CareDx (CDNA) | United States | $1.102B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.775B | 0.00 |
SBC Medicals (SBC) | United States | $0.649B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
DocGo (DCGO) | United States | $0.444B | 16.73 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
Enhabit (EHAB) | United States | $0.387B | 33.48 |
Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
LifeMD (LFMD) | United States | $0.212B | 0.00 |
Biodesix (BDSX) | United States | $0.198B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
Nutex Health (NUTX) | United States | $0.160B | 0.00 |
ModivCare (MODV) | United States | $0.156B | 8.44 |
MultiPlan (MPLN) | United States | $0.108B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
So-Young (SY) | China | $0.093B | 15.69 |
IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.037B | 0.00 |
NeueHealth (NEUE) | United States | $0.033B | 0.87 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
Oncology Institute (TOI) | United States | $0.016B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |